1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B484748A78E9946585256EAD00501A8D
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/clinical-trial-library-service?opendocument
18
19opendocument
2034.207.82.217
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25SPCL




Products & Services

Clinical Trial Excellence Library Service

ID: OPS-85


Published: Pre-2014


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

Save 14% off the reports in this value bundle!

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • INCLUDED RESEARCH
Excellent clinical trials can significantly reduce costs by preventing delayed product launch due to trial length. In saving time during clinical trials, effective clinical communications and top-notch investigators are critical drivers. To enable this process, Best Practices, LLC has developed a new series -- the Clinical Trial Excellence Library Service.


This Best Practices Benchmarking™ toolkit uncovers how clinical operation leaders shrink study times, reduce costs, improve study quality, and move development-stage products more rapidly toward the marketplace. Research metrics, process insights and executive interviews probe three operations required for high performance: 1) recruiting high-performing investigators, 2) clinical investigator relationship management systems, and 3) best practices in communicating the value of clinical trials to potential investigators.

For more information, contact Susan Silverstein at 919-767-9227.


Industries Profiled:
Medical Device; Pharmaceutical; Research; Biotech; Manufacturing; Consumer Products; Diagnostic; Professional Services; Health Care


Companies Profiled:
3M Pharmaceuticals; Sanofi-aventis; AAI Corporation; AAI Development; Abbott Laboratories; ALTANA Pharmaceuticals; America's Doctor; Amersham; Amgen; AstraZeneca; Baxter Healthcare; Bayer; BBK Healthcare; Biologicals International; Bristol-Myers Squibb; Central Texas Clinical Research; Covance; East Bay Clinical Trial Center; Eli Lilly; Eli Lilly and Company; Genesis Clinical Research Corporation; GlaxoSmithKline; Health Decisions; Human Genome Sciences; ICON; Janssen; Merck; Nashville Clinical Research; Novartis; Panacos Pharmaceuticals; Parexel; Perlegen Sciences; Pfizer; Pharmacia; PLIVA Pharmaceuticals; PPD; PPD Development; Richard H. Weisler & Associates; Roche; Schering-Plough; Spartanburg Pharmaceutical; Virginia Commonwealth University; Wake Forest University


Study Snapshot

The Excellence Series offers critical insights and benchmark data on areas such as:
  • How superior investigator management helps Pharma leaders win 50-80% higher investigator performance ratings.
  • How top clinical teams commence investigator selection and recruitment 3-6 months earlier than average companies;
  • How best practitioners cut precious weeks off recruitment cycle-time by identifying and recruiting investigators 2-4 times faster than competitors.
  • Why clinical operations heads rate clinical publications twice as effective as other tactics in building investigator credibility.
  • What factors motivate investigators to choose one study over another.
  • Why some protocol-design approaches receive 50% higher ratings for engaging investigators.

Also covered, are tactics to:
  • Increase the attractiveness and credibility of their studies through effective positioning to different investigator groups
  • Identify key opinion leaders and investigators for protocol design input and clinical trials
  • Evaluate the commitment and qualifications of these investigators
  • Partner to leverage CRO expertise
  • Integrate communication needs into the design of a clinical study
  • Avoid the “class effect” in which study results favorably impact other brands
  • Leverage study results to positively impact other indications for the same brand
  • More!



This bundle combines all of the individual research listed below into one easy-to-purchase transaction. Read individual research abstracts by clicking the titles. Return to this page to add the bundle to your cart.